Opthea (OPT) Revenue & Revenue Breakdown
Opthea Revenue Highlights
Latest Revenue (Y)
$108.41K
Latest Revenue (Q)
$61.27K
Opthea Revenue by Period
Opthea Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-06-30 | $108.41K | 19.54% |
2022-06-30 | $90.68K | 32.17% |
2021-06-30 | $68.61K | 100.00% |
2020-06-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2009-06-30 | - | -100.00% |
2008-06-30 | $14.35K | -24.98% |
2007-06-30 | $19.13K | 100.00% |
2006-06-30 | - | -100.00% |
2005-06-30 | $13.34K | 9.06% |
2004-06-30 | $12.24K | 100.00% |
2003-06-30 | - | -100.00% |
2002-06-30 | $9.57K | 100.00% |
2001-06-30 | - | 100.00% |
2000-06-30 | - | -100.00% |
1999-06-30 | $2.94B | 1524696.35% |
1998-06-30 | $192.74K | -19.86% |
1997-06-30 | $240.51K | 100.00% |
1996-06-30 | - | 100.00% |
1995-06-30 | - | 100.00% |
1994-06-30 | - | 100.00% |
1993-06-30 | - | - |
Opthea Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2023-12-31 | $61.27K | 9.67% |
2023-06-30 | $55.87K | -60.31% |
2023-03-31 | $140.76K | 170.49% |
2022-12-31 | $52.04K | -66.22% |
2022-09-30 | $154.06K | 237.59% |
2022-06-30 | $45.63K | 49.67% |
2022-03-31 | $30.49K | -71.11% |
2021-12-31 | $105.54K | -0.54% |
2021-09-30 | $106.12K | -199.15% |
2021-06-30 | $-107.03K | 1.30% |
2021-03-31 | $-105.66K | -160.07% |
2020-12-31 | $175.90K | 100.00% |
2020-09-30 | - | -100.00% |
2020-06-30 | $72.59K | 100.00% |
2020-03-30 | - | 100.00% |
2020-01-30 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-30 | - | -100.00% |
2018-12-31 | $45.96K | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-30 | - | -100.00% |
2017-12-31 | $24.71K | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-30 | - | 100.00% |
2017-01-30 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-30 | - | 100.00% |
2016-01-30 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-30 | - | 100.00% |
2015-01-30 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-30 | - | 100.00% |
2014-01-30 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-30 | - | 100.00% |
2013-01-30 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-30 | - | 100.00% |
2012-01-30 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | 100.00% |
2011-03-30 | - | 100.00% |
2011-01-30 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-30 | - | 100.00% |
2010-01-30 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-30 | - | 100.00% |
2009-01-30 | - | -100.00% |
2008-09-30 | $2.89K | 100.00% |
2008-06-30 | - | -100.00% |
2008-03-30 | $3.44K | 2.02% |
2008-01-30 | $3.37K | -32.27% |
2007-09-30 | $4.98K | 100.00% |
2007-06-30 | - | -100.00% |
2007-03-30 | $5.64K | - |
2007-01-30 | $5.64K | 100.00% |
2006-09-30 | - | 100.00% |
2006-06-30 | - | 100.00% |
2006-03-30 | - | 100.00% |
2006-01-30 | - | -100.00% |
2005-09-30 | $4.38K | - |
Opthea Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ADAG | Adagene | $18.11M | $833.34K |
MOLN | Molecular Partners | $7.04M | $2.74M |
INBX | Inhibrx Biosciences | $1.80M | - |
MNOV | MediciNova | $1.00M | - |
OPT | Opthea | $108.41K | $61.27K |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
ANTX | AN2 Therapeutics | - | - |
AVTE | Aerovate Therapeutics | - | - |
CYT | Cyteir Therapeutics | - | - |
ELYM | Eliem Therapeutics | - | - |
ACRV | Acrivon Therapeutics | - | - |
MLYS | Mineralys Therapeutics | - | - |
CSBR | Champions Oncology | - | - |